课题基金 / 基金详情

项目摘要

项目成果

JUNMIN PENG的其他基金

相似基金

相关文献

中文摘要
翻译
这项研究的长期目标是识别和验证神经退行性变发展过程中的蛋白质组变化。阿尔茨海默病(AD)和帕金森病(PD)是两种最常见的神经退行性疾病。虽然阿尔茨海默病和帕金森病被认为是不同的疾病,但存在显著的重叠。轻度认知障碍(MCI)是介于健康衰老和痴呆症之间的一种短暂状态,通常代表着与退行性痴呆疾病相关的认知功能衰退的非常早期阶段。在组织病理学上,异常蛋白的积聚被认为是AD和PD神经变性的标志,提示共同的分子机制可能参与了AD、PD和AD/PD重叠障碍的神经变性的发病机制。利用基于新的质谱学技术,我们将检验我们的中心假说:泛素化蛋白质组和突触后蛋白质组的变化将揭示AD、PD和AD/PD重叠综合征之间的分子共性,蛋白质模式的变化将伴随着疾病从MCI向AD的演变。我们 将使用临床特征良好的人类尸检样本来评估泛素化蛋白质组和突触后密度(PSD)中的蛋白质模式变化。MCI、AD、PD和AD/PD重叠疾病的样本将被分析和比较,以发现共同的蛋白质模式。这些蛋白质的变化将在一大批疾病病例中得到进一步证实。这一结果将使识别潜在的生物标志物成为可能,并为随后的神经退行性变研究提供关键的分子图谱。
英文摘要
The long-term goal of this research is to identify and validate the proteomic changes in the development of neurodegeneration. Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative diseases. Although AD and PD are considered distinct disorders, significant overlap occurs. Mild cognitive impairment (MCI) is a transient state between healthy aging and dementia, often representing a very early stage of cognitive decline associated with a degenerative dementing illness. Histopathologically, accumulation of abnormal proteins has been recognized as hallmarks of neurodegeneration in both AD and PD, suggesting that shared molecular mechanisms may mediate the pathogenesis of neurodegeneration in AD, PD, and AD/PD overlap disorders. Using novel mass spectrometry-based technologies, we will test our central hypothesis: changes in the ubiquitinated proteome and the postsynaptic proteome will reveal molecular commonality among AD, PD, and AD/PD overlap syndromes, and changes in protein patterns will accompany the evolution of disease from MCI to AD. We will use clinically well-characterized human postmortem samples to evaluate protein pattern changes in the ubiquitinated proteome and in the postsynaptic density (PSD). Samples of MCI, AD, PD and AD/PD overlap disease will be analyzed and compared to discover shared protein patterns. These protein changes will be further confirmed in a large set of disease cases. The results will enable the identification of potential biomarkers and provide critical molecular maps for subsequent studies of neurodegeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-Omics Core
  • 批准号:
    10667454
  • 项目类别:
  • 资助金额:
    $60.01万
  • 财政年份:
    2021
  • 负责人:
    JUNMIN PENG
  • 依托单位:
Multi-Omics Core
  • 批准号:
    10407941
  • 项目类别:
  • 资助金额:
    $60.19万
  • 财政年份:
    2021
  • 负责人:
    JUNMIN PENG
  • 依托单位:
Dissecting neuron-microglia-astrocyte interaction in AD pathogenesis
Dissecting neuron-microglia-astrocyte interaction in AD pathogenesis
海外基金